Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a broad and poorly defined group of biological structures located on the cell exterior and within the surrounding tissue scaffold. It is primarily used as a placeholder in pharmacological databases like ChEMBL for drugs that do not have a single, well-characterized molecular target (ChEMBL, 2024). The components involved include a variety of proteins, such as collagen and laminin, as well as complex carbohydrates like heparan sulfate (NCBI, 2002). Drugs associated with this classification often work through non-specific mechanisms, such as forming physical barriers or utilizing ionic charges to adhere to tissue surfaces. For instance, certain gastroprotective agents bind to the proteins exposed in gastric ulcers to prevent further acid damage. Because the category is heterogeneous, it does not allow for the precise molecular modeling or structure-activity relationship studies typical of specific protein targets. Consequently, it is not considered a valid therapeutic target in the context of modern drug discovery but rather a functional grouping for non-specific agents. This lack of specificity presents challenges in predicting off-target effects and understanding the exact pharmacokinetics of the interacting drugs.
Non-specific binding, physical barrier formation, or ionic interaction with various cell-surface and extracellular matrix elements.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous cell-surface and extracellular matrix components.